Northwestern Mutual Wealth Management
CGTX icon

Northwestern Mutual Wealth Management’s Cognition Therapeutics CGTX Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio CGTX Stock Details CGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.1K Hold
17,467
– – ﹤0.01% 2871
2026
Q1 		$13.3K Hold
17,467
– – ﹤0.01% 2962
2025
Q4 		$23.6K Hold
17,467
– – ﹤0.01% 2683
2025
Q3 		$23.6K Buy
17,467
+700
+4% +$955 ﹤0.01% 2613
2025
Q2 		$5.19K Buy
16,767
+10,200
+155% +$3.44K ﹤0.01% 3009
2025
Q1 		$2.76K Buy
6,567
+700
+12% +$411 ﹤0.01% 3074
2024
Q4 		$4.12K Hold
5,867
– – ﹤0.01% 2998
2024
Q3 		$2.75K Hold
5,867
– – ﹤0.01% 3054
2024
Q2 		$9.74K Hold
5,867
– – ﹤0.01% 2654
2024
Q1 		$10.7K Hold
5,867
– – ﹤0.01% 2623
2023
Q4 		$10.9K Hold
5,867
– – ﹤0.01% 2604
2023
Q3 		$8.45K Hold
5,867
– – ﹤0.01% 2599
2023
Q2 		$10.7K Hold
5,867
– – ﹤0.01% 2548
2023
Q1 		$11.6K Hold
5,867
– – ﹤0.01% 2458
2022
Q4 		$12.3K Buy
+5,867
New +$11.8K ﹤0.01% 2416

Other funds holding CGTX

DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HCM
Hilton Capital Management Garden City, New York $1.47B AUM 18.73% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.97B AUM 32.34% 1-Year Est. Return

Northwestern Mutual Wealth Management's CGTX Position: Q2 2026 in Review

Northwestern Mutual Wealth Management held its Cognition Therapeutics (CGTX) position steady in Q2 2026 at 17,467 shares worth $20.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2871.

Northwestern Mutual Wealth Management first reported a position in CGTX in Q4 2022 and has held it in 15 quarters since. The position peaked at $23.6K in Q4 2025. 53 funds tracked by Wall St. Rank hold CGTX as of Q2 2026.

  • Northwestern Mutual Wealth Management held 17,467 shares of Cognition Therapeutics worth $20.1K as of Q2 2026.
  • Northwestern Mutual Wealth Management left its Cognition Therapeutics share count unchanged in Q2 2026.
  • Cognition Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #2871 holding.
  • Northwestern Mutual Wealth Management first reported a position in Cognition Therapeutics in Q4 2022 and has held it in 15 quarters since.
  • Northwestern Mutual Wealth Management's Cognition Therapeutics position peaked at $23.6K in Q4 2025.
  • 53 funds tracked by Wall St. Rank held Cognition Therapeutics as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.